NVUS $4.35 +0.12 (2.84%)
Wed, Feb 20, 2019
Novus Therapeutics, Inc. - Common Stock is a Health Care stock that trades on the NASDAQ with a market cap of $40 Million
Novus Therapeutics Inc is engaged in the biotechnology sector. As a pharmaceutical company, it is focused on the acquisition, development, and commercialization of ear, nose, and throat related products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. http://www.novustherapeutics.com
Novus Therapeutics, Inc. - Common Stock Stock Charts
NVUS Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $4.35.
The Year To Date (YTD) return is +162.05%.
52 Week Low
The 52 Week Low stock price is $1.52 set on Wed, Dec 26, 2018 which is 57 days ago.
The current price per share is 186.18% above the 52 week low.
52 Week High
The 52 Week High stock price is $8.18 set on Thu, May 31, 2018 which is 266 days ago.
The current price per share is -46.82% below the 52 week high.
All Time High
The All Time High stock price is $8.18 set on Thu, May 31, 2018 which is 266 days ago.
The current price per share is -46.82% below the all time high.
NVUS Stock Split History
Novus Therapeutics, Inc. - Common Stock has had 1 stock splits.
|Split Date||Split Ratio|
|Thu, May 11, 2017||9 for 1|
Below is the EPS, P/E Ratio and Earnings Date.
The EPS is -$0.37 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Novus Therapeutics, Inc. - Common Stock was Tue, Aug 7, 2018.
Since this earnings release 198 days ago, the stock price is down by -19.74%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Tue, Nov 13, 2018, which was 100 days ago.
Since this earnings date, the stock price is up by +9.30%.
Novus Therapeutics, Inc. - Common Stock Dividend
Below is important Dividend information.
NVUS currently does not pay a dividend.
You may like this list of best dividend stocks of 2019.
Below are some other Biotech & Pharma industry stocks like Novus Therapeutics, Inc. - Common Stock.